Neuronetics Receives FDA 510(k) Premarket Notification Clearance For The Neurostar TMS Therapy System For Mental Health
accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K220127
Neuronetics Announces TMS Coverage Policies To Expand Patient Access To NeuroStar TMS Therapy For Mental Health
Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need it with the best neurohealth therapies in
Recap: Neuronetics Q1 Earnings
Neuronetics (NASDAQ:STIM) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
52 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247 million.
Neuronetics Reports Filed Federal Suit Against Brainsway For ‘Misleading Psychiatrists, Patients’
Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders,
NeuroStar Advanced Therapy For Mental Health Announces Partnership With Mental Health Advocate And Former Major League Baseball Player Drew Robinson
NeuroStar Advanced Therapy for Mental Health Announces Partnership with Mental Health Advocate and Former Major League Baseball Player Drew Robinson
A Media Snippet accompanying this announcement is available by
Neuronetics Earnings Conference Call Is Coming Up, Here’s What You Need To Know
Neuronetics (NASDAQ:STIM) will host a conference call at 08:30 AM ET on May 12, 2022, to discuss Q1 2022 earnings results.
How to Attend Neuronetics (STIM) Conference Call
Follow this link to access the live webcast.
